Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 9, Number 3—March 2003
Dispatch

Persistence of Virus-Reactive Serum Immunoglobulin M Antibody in Confirmed West Nile Virus Encephalitis Cases

John T. Roehrig*Comments to Author , Denis Nash†, Beth Maldin†, Anne Labowitz†, Denise A. Martin*, Robert S. Lanciotti*, and Grant L. Campbell*
Author affiliations: *Centers for Disease Control and Prevention, Fort Collins, Colorado, USA; †New York City Department of Health, New York, New York, USA

Main Article

Table 1

IgM and IgG P/N values of WNV virus patient serum samples by days after onseta

Case no. Sample Days after onset WNV IgM WNV IgG
1
 S1
 12
 14.3
 2.0
S2
 197
 3.9
 7.8
S3
 340
 3.5
 8.2
S4
 498
 2.8
 nda
2
 S1
 97
 12.0
 5.3
S2
 378
 3.2
 nd
3
 S1
 72
 8.2
 5.0
S2
 186
 7.3
 7.0
S3
 388
 1.0
 nd
4
 S1
 27
 17.3
 3.4
S2
 311
 2.7
 6.4
5
 S1
 31
 11.0
 5.5
S2
 215
 2.8
 7.9
S3
 374
 1.3
 nd
6
 S1
 39
 5.9
 2.8
S2
 173
 7.6
 3.9
S3
 332
 3.5
 4.3
S4
 502
 3.1
 nd
7
 S1
 29
 11.5
 4.8
S2
 189
 6.7
 6.3
S3
 332
 2.7
 6.2
S4
 536
 2.8
 nd
8
 S1
 3
 3.3
 6
S2
 15
 10.7
 5.0
S3
 30
 nd
 5.3
S4
 43
 4.1
 5.4
S5
 204
 3.5
 6.2
S6
 343
 2.2
 7.0
S7
 508
 1.8
 nd
9
 S1
 21
 13.6
 4.4
S2
 199
 1.7
 3.2
10
 S1
 55
 9.0
 3.7
S2
 189
 10.8
 6.0
11
 S1
 17
 24.6
 5.2
S2
 255
 3.6
 4.3
S3
 336
 3.1
 7.5
S4
 512
 6.9
 nd
12
 S1
 11
 13.4
 5.3
S2
 13
 15.0
 5.6
S3
 24
 11.4
 5.8
S4
 533
 1.8
 nd
13
 S1
 8
 16.7
 3.4
S2
 202
 4.2
 nd
14
 S1
 16
 7.8
 2.4
S2
 30
 3.5
 5.6
S3
 349
 1.7
 7.0
15
 S1
 17
 17.2
 5.6
S2
 192
 2.2
 6.3
S3
 335
 1.4
 6.8
16
 S1
 7
 14.0
 2.0
S2
 29
 24.5
 3.7
S3
 338
 6.5
 6.6
17
 S1
 79
 8.5
 5.7
S2
 200
 7.5
 4.5
S3
 337
 4.1
 4.6
S4
 525
 3.6
 nd
18
 S1
 50
 7.3
 4.8
S2
 55
 6.6
 3.3
S3
 68
 4.4
 nd
S4
 207
 2.9
 7.3
S5
 505
 1.3
 nd
19
 S1
 4
 10.5
 4.0
S2
 14
 7.3
 4.1
S3
 355
 1.3
 nd
20
 S1
 29
 18.0
 3.1
S2
 257
 3
 8.8
S3
 373
 1.7
 nd
21
 S1
 1
 10.1
 3.6
S2
 7
 9.2
 3.5
S3
 180
 1.2
 2.8
22
 S1
 6
 25.7
 2.4
S2
 185
 9.1
 6.9
S3
 319
 3.4
 8.2
S4
 497
 4.2
 Nd
23
 S1
 25
 12.3
 5.5
S2
 204
 3.0
 7.2
S3
 529
 1.7
 nd
24
 S1
 4
 11.4
 3.2
S2
 8
 9.1
 3.5
S3
 14
 19.6
 2.7
S4
 212
 2.9
 6.3
S5
 361
 1.9
 nd
25
 S1
 9
 9.1
 4.8
S2
 34
 6.7
 5.2
S3
 223
 1.5
 5.0
26
 S1
 10
 14.8
 2.3
S2
 22
 16.1
 3.7
S3
 191
 10.4
 3.2
S4
 387
 3.4
 nd
S5
 514
 5.2
 nd
27
 S1
 3
 11.1
 3.7
S2
 180
 7.8
 5.8
S3
 322
 5.1
 8.3
S4
 518
 2.4
 nd
28
 S1
 26
 4.9
 6.0
S2
 32
 4.3
 5.6
S3
 298
 2.2
 nd
29 S1
 217
 2.4
 6.7
S2 351 1.8 8.1

a Ig, immunoglobulin; P/N, positive-to-negative; WNV, West Nile virus nd, not done.

Main Article

Page created: December 07, 2010
Page updated: December 07, 2010
Page reviewed: December 07, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external